Trial Profile
A phase I/IIa clinical study of TERT-induced adoptive T cell therapy
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 Nov 2017
Price :
$35
*
At a glance
- Drugs TERT-induced adoptive T cell therapy - Eutilex (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 16 Nov 2017 New trial record